Alyaa Wessam
Summary
Healthcare professional with 20 years of pharmaceutical experience in oncology, cardiology, and primary care across Australia and the Middle East. Currently pursuing a Master's degree in Health Leadership and Management at UNSW. Expertise in stakeholder engagement, cross-functional collaboration, and medical education. Aiming to leverage clinical knowledge and strategic insight in a Medical Affairs or Medical Science Liaison role.
Overview
24
24
years of professional experience
Work History
Medical Science Liaison
Ferring Pharmaceuticals
Melbourne , Australia
08.2025 - Current
- Medical Science Liaison, Oncology and Reproductive Medicine, supporting the launch of Adstiladrin gene therapy in high-risk, non-muscle invasive bladder cancer, alongside a 20% remit for Menopur and Rekovelle in fertility.
- Providing in-depth education on gene therapy mechanisms, pivotal data, and positioning in the treatment pathway for BCG-unresponsive NMIBC.
- Supporting global Phase 4 ABLE-32 and ABLE-41 studies by engaging identified KEEs, discussing protocol requirements, screening pathways, and recruitment barriers, and maintaining regular follow-up on site activation and enrollment.
- Coordinating a medically-led international speaker roadshow on gene therapy for bladder cancer by March 2026.
- Providing scientific support for Menopur and Rekovelle across ART centers, with a focus on evidence-based ovarian stimulation and individualized treatment strategies.
- Identifying IIS opportunities for Menopur and Rekovelle, including early concept discussions with investigators, feasibility assessment, and alignment with medical strategy.
Medical Science Liaison
Astellas
Melbourne , Australia
08.2023 - 07.2025
- Medical Science Liaison for GU and GI oncology, with a primary focus on Enfortumab Vedotin in urothelial cancer and biomarker-driven strategies in GI malignancies.
- Identified and engaged key opinion leaders in GI and GU oncology to discuss evolving data on antibody–drug conjugates and biomarker-selected therapies, generating insights to inform medical strategy.
- Provided in-depth scientific support on Enfortumab Vedotin, including pivotal trial data, safety profile, and positioning within urothelial/bladder cancer treatment algorithms, through peer-to-peer scientific exchange with oncologists and urologists.
- Delivered non-promotional education to multidisciplinary teams on optimal patient selection, sequencing, and management of treatment-related adverse events to support safe, evidence-based use.
- Acted as field medical lead for the launch preparation of Zolbetuximab in GI cancers, with a strong focus on integrating CLDN18.2 biomarker testing into clinical practice.
- Educated medical oncologists, gastroenterologists, pathologists, and nurses on the clinical relevance of CLDN18.2, testing pathways, and implications for patient selection for Zolbetuximab.
- Planned and executed the medical components of national and regional advisory boards and masterclasses, including KOL identification, briefing, agenda shaping, and post-meeting insight synthesis to refine medical and launch strategy.
- Partnered closely with commercial colleagues as the scientific lead for the oncology portfolio, and delivered scientific training for the field force, improving their clinical confidence.
Oncology Business Specialist
Astellas Australia
Melbourne, Australia
05.2021 - 08.2023
- Built strong, trusted relationships with medical oncologists, urologists, gastroenterologists, radiation oncologists, and pharmacists, leading to increased product adoption.
- Exceeded oncology sales targets for GU and GI tumor streams.
- Drove market share growth for Astellas’ oncology portfolio through focused targeting, effective territory business plans, and disciplined follow-up with high-value prescribers.
- Collaborated with internal stakeholders on patient access projects.
- Delivered high-quality, evidence-based product discussions, and in-service education that supported optimal treatment decisions in complex GU and GI cancer pathways.
- Led key account planning with cross-functional partners (medical and marketing) to improve access and streamline treatment pathways for GU and GI patients.
- Conducted competitive analysis to support sales strategies and identify market gaps.
Territory Manager
Bayer Australia
Melbourne, Australia
08.2018 - 04.2021
- Promoted Xarelto to cardiologists and specialists.
- Met or exceeded established targets for revenue growth month over month.
- Developed targeted marketing campaigns designed to reach specific audiences in the territory.
- Led KOL initiatives, competitive analysis, and strategic educational planning.
- Provided training and support to team members on product knowledge, sales techniques, and customer engagement.
GP Medical Representative
GSK Australia
Melbourne, Australia
01.2017 - 07.2018
- Promoted respiratory therapies.
- Ranked 4th nationally for market share growth.
- Created detailed reports of sales activities including customer feedback, competitor analysis, and market trends.
- Collaborated with marketing teams on promotional materials such as brochures and leaflets.
Child Advocate
UNICEF Australia
Melbourne, Australia
10.2016 - 01.2017
- Led public engagement campaigns across retail locations.
- Built donor relationships and raised awareness for global child welfare and humanitarian programs.
- Cultivated relationships with new prospects through networking events, cold-calling, and emails.
- Processed donor contributions, including tracking funds received, and issuing receipts or thank-you notes.
Scientific Advisor
Medcells FZLLE
UAE, United Arab Emirates
05.2015 - 05.2016
- Promoted stem cell storage.
- Developed effective relationships with key influencers and external organizations.
- Analyzed data from clinical trials and studies to provide insights into trends or patterns.
- Prepared presentations and documents for medical advisory boards.
- Developed training materials for medical staff on best practices.
- Responded promptly to inquiries from customers regarding product information.
Specialist Medical Representative
Pfizer Inc.
UAE, United Arab Emirates
04.2011 - 05.2015
- Promoted the pain portfolio to MOH and DHA.
- Surpassed sales targets.
- Mapped key accounts, supported product access, and trained field teams.
- Analyzed competitors' data and pricing models to maintain competitive advantage in the marketplace.
- Updated customer information in CRM database daily to document latest interactions and activity.
Specialist Medical Representative
Merck & Co. (via Schering-Plough)
UAE, United Arab Emirates
01.2010 - 04.2011
- Promoted Aerius and Nasonex (respiratory products) to the private sector accounts.
- Achieved and exceeded sales targets.
- Built strong client networks, and helped train new team members.
- Participated in trade shows, conferences, and other events to promote medical products.
Medical Representative
Schering-Plough
UAE, United Arab Emirates
01.2006 - 01.2010
- Drove sales growth across product launches.
- Delivered product education and supported prescribers through seminars and field visits.
- Developed relationships with key opinion leaders within the medical community.
- Identified new business opportunities through networking activities.
Medical Representative
Pharma World
UAE, United Arab Emirates
09.2004 - 01.2006
- Launched and positioned a vitamin product line in retail pharmacies across the UAE.
- Ensured product availability and HCP awareness.
- Collaborated with marketing teams on promotional materials such as brochures and leaflets.
- Maintained records of sales activities such as appointments made, calls placed, samples distributed.
Medical Representative
Novartis Pharma (CNS Business Unit)
Cairo, Egypt
01.2002 - 06.2004
- Promoted Leponex and Trileptal (CNS Products) in hospitals and private clinics.
- Consistently exceeded sales targets.
- Organized scientific events to support CNS treatment access.
Education
Master of Health Leadership & Management -
University of New South Wales (UNSW)
Sydney, Australia12.2025
Bachelor of Pharmacy -
Cairo
EgyptSkills
- Clinical research
- Patient education
- Data analysis
- Customer engagement
- Cross-functional team coordination
- Strategic planning
Timeline
Medical Science Liaison
Ferring Pharmaceuticals
08.2025 - Current
Medical Science Liaison
Astellas
08.2023 - 07.2025
Oncology Business Specialist
Astellas Australia
05.2021 - 08.2023
Territory Manager
Bayer Australia
08.2018 - 04.2021
GP Medical Representative
GSK Australia
01.2017 - 07.2018
Child Advocate
UNICEF Australia
10.2016 - 01.2017
Scientific Advisor
Medcells FZLLE
05.2015 - 05.2016
Specialist Medical Representative
Pfizer Inc.
04.2011 - 05.2015
Specialist Medical Representative
Merck & Co. (via Schering-Plough)
01.2010 - 04.2011
Medical Representative
Schering-Plough
01.2006 - 01.2010
Medical Representative
Pharma World
09.2004 - 01.2006
Medical Representative
Novartis Pharma (CNS Business Unit)
01.2002 - 06.2004
Master of Health Leadership & Management -
University of New South Wales (UNSW)
Bachelor of Pharmacy -
Cairo